Table 3. Rates of myocardial infarction per 1,000 persons per year (PY) in men under age 65 years and those age 65 years and older, in pre- and post-prescription intervals for an initial prescription for PDE5I with adjusted* rate ratios (RR), and 95% confidence intervals (CI).
All Ages | Age <65Years | Age ≥65Years | |
Patients (N) | 167,279† | 141,512† | 25,767† |
Pre-prescription | |||
Cases | 695 | 556 | 139 |
Rate per 1,000 PY (95%CI) | 3.48 (3.02, 4.01) | 3.22 (2.75, 3.77) | 5.27 (3.81, 7.27) |
Post-prescription | |||
Cases | 152 | 119 | 33 |
Rate per 1,000 PY (95%CI) | 3.75 (3.19, 4.40) | 3.42 (2.76, 4.24) | 6.06 (4.26, 8.63) |
Rate Ratio (post/pre) (95%CI) | 1.08 (0.93, 1.24) | 1.06 (0.91, 1.24) | 1.15 (0.83, 1.59) |
Adjusted for age and pre-existing medical conditions and medication use associated with MI or its risk factors (Table 1 and Supplemental Tables).
Effective sample sizes of PDE5I cohorts after weighting:
All Ages: 141,671.
Age <65: Years 121,696.
Age ≥65: Years 19,505.